These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Lane RJ; McLean KA; Moss J; Woodrow DF Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024 [TBL] [Abstract][Full Text] [Related]
5. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Pezeshkpour G; Illa I; Dalakas MC Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434 [TBL] [Abstract][Full Text] [Related]
7. HIV or zidovudine myopathy? Kieburtz K Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309596 [No Abstract] [Full Text] [Related]
8. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy. Chariot P; Bonne G; Authier FJ; Marsac C; Gherardi R J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166 [TBL] [Abstract][Full Text] [Related]
9. Prognosis in AZT myopathy. Chalmers AC; Greco CM; Miller RG Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057 [TBL] [Abstract][Full Text] [Related]
10. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection. Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255 [TBL] [Abstract][Full Text] [Related]
11. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Schröder JM; Bertram M; Schnabel R; Pfaff U Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495 [TBL] [Abstract][Full Text] [Related]
13. 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients. Weissman JD; Constantinitis I; Hudgins P; Wallace DC Neurology; 1992 Mar; 42(3 Pt 1):619-23. PubMed ID: 1549225 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial myopathy caused by long-term zidovudine therapy. Gold R; Meurers B; Reichmann H N Engl J Med; 1990 Oct; 323(14):994. PubMed ID: 2402267 [No Abstract] [Full Text] [Related]
15. Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Chariot P; Monnet I; Mouchet M; Rohr M; Lefaucheur JP; Dubreuil-Lemaire ML; Chousterman M; Gherardi R Arthritis Rheum; 1994 Apr; 37(4):583-6. PubMed ID: 8147937 [TBL] [Abstract][Full Text] [Related]
16. Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease? Le Bras P; D'Oiron R; Quertainmont Y; Halfon P; Caquet R AIDS; 1994 May; 8(5):716-7. PubMed ID: 8060560 [No Abstract] [Full Text] [Related]